Novartis Venture Fund Investors
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Invests into
Acquisitions Number:
NA
Headquarters:
Basel, Basel-Stadt, Switzerland
Funding Status:
N/A
Zip:
NA
Employee Number:
11-50
Estimated Revenue:
107.46 USD
Investment Stage:
Early Stage Venture, Late Stage Venture, Post-Ipo, Secondary Market, Seed
Number Of Exists:
67
Investor Type:
Not Classified
Investors Number:
NA
Founded Date:
1996-01-01
Industry:
Innovation, Technology, and Research